Detalhe da pesquisa
1.
HRAS mutation positive multiple myeloma in the type 2 CALR mutation positive essential thrombocythemia: A case report.
J Cell Mol Med
; 27(2): 299-303, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36606310
2.
SARS-CoV-2 Infection in Patients Treated with Azacitidine and Venetoclax for Acute Leukemia: A Report of a Case Series Treated in a Single Institution.
Chemotherapy
; 68(1): 16-22, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36103840
3.
FGFR2 point mutation in 2 cases of pleomorphic adenoma progressing to myoepithelial carcinoma.
Contemp Oncol (Pozn)
; 27(3): 211-216, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-38239864
4.
Targeting integrated stress response with ISRIB combined with imatinib treatment attenuates RAS/RAF/MAPK and STAT5 signaling and eradicates chronic myeloid leukemia cells.
BMC Cancer
; 22(1): 1254, 2022 Dec 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36460969
5.
The Clinical Tumor Lysis Syndrome in a Patient with Mixed Phenotype Acute Leukemia Undergoing Induction with Venetoclax and Azacitidine: A Case Report.
Chemotherapy
; 67(3): 173-177, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35325891
6.
Predictive significance of selected gene mutations in relapsed and refractory chronic lymphocytic leukemia patients treated with ibrutinib.
Eur J Haematol
; 106(3): 320-326, 2021 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-33190294
7.
Whole-exome sequencing in patients with protein aggregate myopathies reveals causative mutations associated with novel atypical phenotypes.
Neurol Sci
; 42(7): 2819-2827, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-33170376
8.
Co-occurrence of unclassified myeloproliferative neoplasm and giant cell arteritis in a patient treated with allogeneic hematopoietic stem cell transplantation: a case report and literature review.
Cent Eur J Immunol
; 46(1): 121-126, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33897294
9.
Tyrosine kinase inhibitor-induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitors.
Blood
; 132(1): 67-77, 2018 07 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29784639
10.
Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases.
Blood
; 127(17): 2131-43, 2016 04 28.
Artigo
Inglês
| MEDLINE | ID: mdl-26864341
11.
A study in Polish patients with cardiomyopathy emphasizes pathogenicity of phospholamban (PLN) mutations at amino acid position 9 and low penetrance of heterozygous null PLN mutations.
BMC Med Genet
; 16: 21, 2015 Apr 03.
Artigo
Inglês
| MEDLINE | ID: mdl-25928149
12.
Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells.
Blood
; 121(20): 4175-83, 2013 May 16.
Artigo
Inglês
| MEDLINE | ID: mdl-23543457
13.
BRAF--a new player in hematological neoplasms.
Blood Cells Mol Dis
; 53(1-2): 77-83, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24495477
14.
Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors.
Blood
; 119(18): 4253-63, 2012 May 03.
Artigo
Inglês
| MEDLINE | ID: mdl-22411871
15.
Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia-positive lymphoid leukemia to tyrosine kinase inhibitors.
Hemasphere
; 8(3): e56, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38486859
16.
Telomere loss is accompanied by decreased pool of shelterin proteins TRF2 and RAP1, elevated levels of TERRA and enhanced glycolysis in imatinib-resistant CML cells.
Toxicol In Vitro
; 90: 105608, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37149272
17.
The interplay between telomeric complex members and BCR::ABL1 oncogenic tyrosine kinase in the maintenance of telomere length in chronic myeloid leukemia.
J Cancer Res Clin Oncol
; 149(10): 7103-7112, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-36871092
18.
A rare mutation in a rare tumor--SMARCB1-deficient malignant glomus tumor.
Genes Chromosomes Cancer
; 55(1): 107-9, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26391213
19.
Analysis of Mutational Profile of Hypopharyngeal and Laryngeal Head and Neck Squamous Cell Carcinomas Identifies KMT2C as a Potential Tumor Suppressor.
Front Oncol
; 12: 768954, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35664801
20.
Tracking Clonal Evolution of Multiple Myeloma Using Targeted Next-Generation DNA Sequencing.
Biomedicines
; 10(7)2022 Jul 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35884979